There is increasing evidence that DARPP‐32, PP1 and Cdk5 have a role in various tumour types; however, expression of DARPP‐32 and PP1 has not previously been described in ovarian cancer, although DARPP‐32 has been implicated in follicular development.20 This evidence concerns the gene CDK5 and neoplasm.